CS logo
small CS logo
Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval

Kharkiv, Ukraine
University in Kharkiv
Nauky Ave, 4, Kharkiv, Kharkivs'ka oblast, 61000

About Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval


Kharkiv National Medical University, formerly known as Kharkiv Medical Institute and previously Kharkiv State Medical University, is a medical university in Kharkiv, Ukraine. In March 2022 many buildings were heavily damaged due to the Russian invasion into Ukraine.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Celgene
4
Hoffmann-La Roche
4
Ferring Pharmaceuticals
3
Janssen Research & Development, LLC
3
Total Rows: 4

Clinical Trials at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval


During the past decade, Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100110033221111000000111122Started TrialsCompleted Trails201520162017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
2007-03-01
2011-12-01
Completed
386
A Trial of Degarelix in Patients With Prostate Cancer
2009-06-01
2011-03-01
Completed
859
A Degarelix Trial in Patients With Prostate Cancer
2010-10-01
2012-01-01
Terminated
288
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients
2012-09-18
2016-05-11
Completed
258
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
2013-12-03
2017-04-13
Completed
1,320
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery
2017-11-13
2018-11-05
Completed
308

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCelgene: 4Celgene: 4Hoffmann-La Roche: 4Hoffmann-La Roche: 4Ferring Pharmaceuticals: 3Ferring Pharmaceuticals: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3

Created with Highcharts 11.1.0Top CollaboratorsBristol-Myers Squibb: 1Bristol-Myers Squibb: 1

Clinical Trials Conditions at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval


According to Clinical.Site data, the most researched conditions in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval" are "Prostate Cancer" (3 trials), "Multiple Sclerosis" (2 trials), "Relapsing Multiple Sclerosis" (2 trials), "Arthroplasty, Replacement, Knee" (1 trials) and "Biliary Tract Cancer" (1 trials). Many other conditions were trialed in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval" in a lesser frequency.

Clinical Trials Intervention Types at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval


Most popular intervention types in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ozanimod" (3 trials), "Atezolizumab" (2 trials), "Degarelix" (2 trials) and "Goserelin acetate" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval


The vast majority of trials in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval" are 10 trials for "All" genders and 4 trials for "Male" genders.

Clinical Trials Status at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval


Currently, there are NaN active trials in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 5Phase 2: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 3Active, not recruiting: 3Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1